Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial
- Vicente Valero
- Paula R. Pohlmann
- Jason Mouabbi
- Xuelin Huang
- Wei Qiao
- Heather Alonzo
- Rashmi K. Murthy
- Gaiane M. Rauch
- Taiwo Adesoye
- Cristina Checka
- Fraser W. Symmans
- Dmitrii Grachev
- Flora Alajajyan
- Adaeze Nwosu-Iheme
- Amy Hassan
- Miral Patel
- Sharon H. Giordano
- Kelly Hunt
- Debasish Tripathy
- Funda Meric-Bernstam
2026-08-22